论文部分内容阅读
为比较艾迪注射液联合化疗与单纯化疗治疗中晚期肺癌的疗效与毒性 ,对观察组 3 2例以艾迪注射液联合化疗 ,对照组 3 0例单纯应用化疗。结果观察组有效率为 3 4 3 7% ,病变进展率为 15 62 % ;对照组有效率为 2 3 3 3 % ,病变进展率 40 % ,2组有效率比较差异无显著性 (P >0 0 5 ) ,而病变进展率差异有显著性 (P <0 0 5 )。治疗后生活质量明显提高 (P <0 0 5 )。治疗中毒副反应明显减少 (P <0 0 5 ) ,差异有显著性。初步研究结果提示 ,艾迪注射液联合化疗治疗中晚期肺癌对稳定病情 ,提高生存质量 ,降低化疗毒副反应作用肯定
To compare the efficacy and toxicity of Aidi Injection with chemotherapy and chemotherapy alone in the treatment of advanced lung cancer, 32 patients in the observation group were treated with Aidi Injection and 30 patients in the control group were treated with chemotherapy alone. Results The effective rate was 34.37% in the observation group and 15 62% in the observation group. The effective rate was 23.3% in the control group and 40% in the pathological change group. There was no significant difference in the effective rate between the two groups (P> 0 0 5), while the rate of pathological changes was significant (P <0 05). After treatment, the quality of life was significantly improved (P <0 05). The side effects of treatment were significantly reduced (P <0 05), the difference was significant. Preliminary results suggest that Aidi injection combined with chemotherapy in the treatment of advanced lung cancer to stabilize the condition, improve the quality of life and reduce the toxic side effects of chemotherapy